Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02420492

Ligand	Ligand name	Chain	PDB	Tanimoto
FOL	FOLIC ACID	A	1PJ6	0.81
FOL	FOLIC ACID	A,B	1RD7	0.81
FOL	FOLIC ACID	A,B	1DHF	0.81
FOL	FOLIC ACID	A,B,C,D,E	1QZF	0.81
FOL	FOLIC ACID	A	4CD2	0.81
FOL	FOLIC ACID	A	1RX7	0.81
FOL	FOLIC ACID	A	1RX2	0.81
FOL	FOLIC ACID	A	1RX8	0.81
FOL	FOLIC ACID	A	1RA2	0.81
FOL	FOLIC ACID	A,B	1RE7	0.81
FOL	FOLIC ACID	A	7DFR	0.81
FOL	FOLIC ACID	A	1VIF	0.81
FOL	FOLIC ACID	A,B	1RB2	0.81
FOL	FOLIC ACID	A	1CD2	0.81
FOL	FOLIC ACID	A	2CD2	0.81
FOL	FOLIC ACID	A,B	1DYI	0.81
FOL	FOLIC ACID	A	1DRF	0.81
FOL	FOLIC ACID	A,B,C,D	3BMC	0.81
FOL	FOLIC ACID	A,B	2D0K	0.81
FOL	FOLIC ACID	A	1RA8	0.81
AGN		A	1GNP	0.7
FE1	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	A,B,C,D	2QHX	0.7
AKP	N-(PYRAZIN-2-YLCARBONYL)LEUCYLISOLEUCYL-N~1~-{1-[2-({1-CARBOXY-2-[4-(PHOSPHONOOXY)PHENYL]ETHYL}AMINO)-1,1-DIHYDROXY-2-OXOETHYL]BUT-3-ENYL}-3-CYCLOHEXYLALANINAMIDE	A,B	1RGQ	0.71
FR3	1-((1R)-1-(HYDROXYMETHYL)-3-(1-NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDY	0.7
FR2	1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDW	0.72
APT	2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)-METHYL]-4-HYDROXY-PTERIDIN-1-IUM	A,B	1QCJ	0.7
859	2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE	A,B	2NO3	0.71
C92	N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide	A,B	3CPB	0.72
CEI	N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE	A,B	2PSJ	0.72
CEI	N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE	A	2F8P	0.72
CEI	N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE	A	1S36	0.72
3IN	N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY-3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO-CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)-3-CHLORO-PYRAZINYL-5-CARBONYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL-PENTANAMIDE	B	2BPZ	0.71
3IN	N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY-3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO-CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)-3-CHLORO-PYRAZINYL-5-CARBONYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL-PENTANAMIDE	B	2BPY	0.71
3IN	N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY-3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO-CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)-3-CHLORO-PYRAZINYL-5-CARBONYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL-PENTANAMIDE	B	1C6X	0.71
985	(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid	A	3F2A	0.72
COP	N-(4-CARBOXY-4-{4-[(2,4-DIAMINO-PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}-BUTYL)-PHTHALAMIC ACID	A	1OHJ	0.72
COP	N-(4-CARBOXY-4-{4-[(2,4-DIAMINO-PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}-BUTYL)-PHTHALAMIC ACID	A	1OHK	0.72
2SM	methyl 2-{[(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl}benzoate	A	3EA4	0.72
IH4	N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL)	A	2BJU	0.71
24X		H,L	2EC9	0.75
DZF	5-DEAZAFOLIC ACID	A,B	2DHF	0.75
DZF	5-DEAZAFOLIC ACID	A,B	1DYH	0.75
DZF	5-DEAZAFOLIC ACID	A,B,C,D	1CDE	0.75
4RB	4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid	A	3BQR	0.74
4QB	3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID	A	1RWN	0.72
BO2	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE	2,H,K,N,V,Y	2F16	0.72